Rhythm Pharmaceuticals (RYTM) PT Raised to $109 at Morgan Stanley
Tweet
Share
E-mailGet Alerts RYTM Hot Sheet
Price: $116.02 -1.34%
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
Morgan Stanley analyst Jeffrey Hung raised the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $109.00 (from $100.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Goldman Sachs Downgrades Douglas AG (DOU:GR) to Sell
- The Gym Group PLC (GYM:LN) PT Raised to GBP2.95 at Berenberg
- Sampo Oyj (SAMPO:FH) (SAXPY) PT Raised to EUR11.20 at Berenberg
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
